Bank of America
ARRY

Bank of America’s Array Biopharma Inc ARRY Stock Holding History

Bank of America’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,000
Closed -$71K – 7618
2018
Q4 		$71K Buy
+5,000
New +$75.8K ﹤0.01% 6077
2018
Q2 		– Sell
-268,000
Closed -$4.37M – 7491
2018
Q1 		$4.37M Buy
268,000
+48,500
+22% +$777K ﹤0.01% 3209
2017
Q4 		$2.81M Buy
+219,500
New +$2.5M ﹤0.01% 3663

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Bank of America's ARRY Position: Q3 2019 in Review

Bank of America sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 772,474 shares — an estimated $35.8M sold.

Bank of America first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $35.8M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Bank of America reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Bank of America sold 772,474 Array Biopharma Inc shares in Q3 2019, an estimated $35.8M.
  • Bank of America first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Bank of America's Array Biopharma Inc position peaked at $35.8M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Bank of America's 13F filing for Q3 2019, filed 14 Nov 2019.